Мироненкова, Ж.В.,
Муссави, М.Э.,
Давлетьянова, А.Ф.,
Mironenkova, Zh.V.,
Moussawi, M.A.,
Davletianova, A.F. (2017) . The possibilities
of conducting the most cost-effective antiretroviral
therapy
are shown.
Conclusion
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа, a promising direction is NF1
therapy with STAT3 inhibitors and immune checkpoint inhibitors